The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-((1-(tert-butylcarbamoyl)azetidin-3-yl)methyl)-N-(3-chloro-4-(6-oxo-1,6-dihydropyridazin-3-yl)phenyl)-1H-indazole-3-carboxamide ID: ALA4559531
PubChem CID: 155558083
Max Phase: Preclinical
Molecular Formula: C27H28ClN7O3
Molecular Weight: 534.02
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)NC(=O)N1CC(Cn2nc(C(=O)Nc3ccc(-c4ccc(=O)[nH]n4)c(Cl)c3)c3ccccc32)C1
Standard InChI: InChI=1S/C27H28ClN7O3/c1-27(2,3)30-26(38)34-13-16(14-34)15-35-22-7-5-4-6-19(22)24(33-35)25(37)29-17-8-9-18(20(28)12-17)21-10-11-23(36)32-31-21/h4-12,16H,13-15H2,1-3H3,(H,29,37)(H,30,38)(H,32,36)
Standard InChI Key: VKTHNGMMHIFEOQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
3.2467 -4.5151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2456 -5.3347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9536 -5.7437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6633 -5.3342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6604 -4.5116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9518 -4.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9553 -6.5587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2459 -6.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2453 -7.7829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9535 -8.1925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6636 -7.7797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6607 -6.9646 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9494 -3.2891 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6559 -2.8784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6534 -2.0612 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3648 -3.2849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4518 -4.0935 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2516 -4.2610 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1094 -2.9465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6554 -3.5541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4525 -3.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7049 -2.6079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1539 -2.0006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3588 -2.1733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6531 -4.9651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4703 -4.9694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0448 -5.5502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6257 -4.9754 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0510 -4.3945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4429 -4.9798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8477 -5.6897 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8553 -4.2743 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4353 -6.3952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8401 -7.1051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6181 -6.3908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2202 -7.1814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9543 -9.0097 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5375 -5.7427 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 7 2 0
3 7 1 0
6 13 1 0
13 14 1 0
14 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 20 1 0
19 16 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
18 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 26 1 0
28 30 1 0
30 31 1 0
30 32 2 0
31 33 1 0
33 34 1 0
33 35 1 0
33 36 1 0
10 37 2 0
2 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 534.02Molecular Weight (Monoisotopic): 533.1942AlogP: 4.13#Rotatable Bonds: 5Polar Surface Area: 125.01Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.34CX Basic pKa: ┄CX LogP: 2.96CX LogD: 2.96Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.36Np Likeness Score: -1.85
References 1. O'Malley DP, Ahuja V, Fink B, Cao C, Wang C, Swanson J, Wee S, Gavai AV, Tokarski J, Critton D, Paiva AA, Johnson BM, Szapiel N, Xie D.. (2019) Discovery of Pyridazinone and Pyrazolo[1,5-a]pyridine Inhibitors of C-Terminal Src Kinase., 10 (10): [PMID:31620238 ] [10.1021/acsmedchemlett.9b00354 ]